[{"address1": "5401 West Kennedy Boulevard", "address2": "Suite 890", "city": "Tampa", "state": "FL", "zip": "33609", "country": "United States", "phone": "813 553 6680", "website": "https://www.pacira.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. The company has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.", "fullTimeEmployees": 788, "companyOfficers": [{"maxAge": 1, "name": "Mr. Frank D. Lee", "age": 56, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 3152376, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shawn M. Cross", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 566787, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren Bullaro Riker", "age": 45, "title": "Principal Accounting Officer & Senior VP of Finance", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1949982, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristen  Williams Esq., J.D.", "age": 50, "title": "Chief Administrative Officer & Secretary", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 1002432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jonathan  Slonin M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 1030566, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  Mesco", "title": "Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anthony  Molloy III, Esq.", "age": 50, "title": "Chief Legal & Compliance Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 581410, "exercisedValue": 802073, "unexercisedValue": 3099}, {"maxAge": 1, "name": "Mr. Christopher C. Young", "age": 52, "title": "Chief Manufacturing Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Krys  Corbett Esq.", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brendan P. Teehan", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 25.73, "open": 25.89, "dayLow": 25.165, "dayHigh": 26.46, "regularMarketPreviousClose": 25.73, "regularMarketOpen": 25.89, "regularMarketDayLow": 25.165, "regularMarketDayHigh": 26.46, "payoutRatio": 0.0, "beta": 0.235, "trailingPE": 55.936172, "forwardPE": 7.7164664, "volume": 932834, "regularMarketVolume": 932834, "averageVolume": 652093, "averageVolume10days": 732480, "averageDailyVolume10Day": 732480, "bid": 26.28, "ask": 26.36, "bidSize": 1, "askSize": 7, "marketCap": 1181281280, "fiftyTwoWeekLow": 18.17, "fiftyTwoWeekHigh": 27.64, "allTimeHigh": 121.95, "allTimeLow": 6.16, "priceToSalesTrailing12Months": 1.6480136, "fiftyDayAverage": 23.1272, "twoHundredDayAverage": 24.32495, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1310003328, "profitMargins": 0.02991, "floatShares": 42565249, "sharesOutstanding": 43021275, "sharesShort": 7220261, "sharesShortPriorMonth": 7282190, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.16780001, "heldPercentInsiders": 0.01879, "heldPercentInstitutions": 1.13783, "shortRatio": 9.67, "shortPercentOfFloat": 0.2455, "impliedSharesOutstanding": 44932722, "bookValue": 16.925, "priceToBook": 1.5533236, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": 21438000, "trailingEps": 0.47, "forwardEps": 3.407, "enterpriseToRevenue": 1.828, "enterpriseToEbitda": 8.7, "52WeekChange": 0.294917, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 26.29, "targetHighPrice": 38.0, "targetLowPrice": 23.0, "targetMeanPrice": 29.71429, "targetMedianPrice": 28.0, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 246334000, "totalCashPerShare": 5.726, "ebitda": 150570000, "totalDebt": 425308000, "quickRatio": 3.379, "currentRatio": 5.256, "totalRevenue": 716790976, "debtToEquity": 58.485, "revenuePerShare": 15.758, "returnOnAssets": 0.02888, "returnOnEquity": 0.02903, "grossProfits": 470651008, "freeCashflow": 78397000, "operatingCashflow": 141436992, "revenueGrowth": 0.065, "grossMargins": 0.65661, "ebitdaMargins": 0.21006, "operatingMargins": 0.07327, "financialCurrency": "USD", "symbol": "PCRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_27508", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.17645, "regularMarketPrice": 26.29, "shortName": "Pacira BioSciences, Inc.", "corporateActions": [], "postMarketTime": 1765580176, "regularMarketTime": 1765573201, "postMarketChangePercent": 0.0, "postMarketPrice": 26.29, "postMarketChange": 0.0, "regularMarketChange": 0.560001, "regularMarketDayRange": "25.165 - 26.46", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 652093, "fiftyTwoWeekLowChange": 8.120001, "fiftyTwoWeekLowChangePercent": 0.44689053, "fiftyTwoWeekRange": "18.17 - 27.64", "fiftyTwoWeekHighChange": -1.3499985, "fiftyTwoWeekHighChangePercent": -0.048842203, "fiftyTwoWeekChangePercent": 29.4917, "longName": "Pacira BioSciences, Inc.", "marketState": "CLOSED", "fiftyDayAverageChange": 3.1628017, "fiftyDayAverageChangePercent": 0.1367568, "twoHundredDayAverageChange": 1.9650517, "twoHundredDayAverageChangePercent": 0.08078338, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "earningsCallTimestampStart": 1762464600, "earningsCallTimestampEnd": 1762464600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.47, "epsForward": 3.407, "epsCurrentYear": 2.96402, "priceEpsCurrentYear": 8.869711, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1296743400000, "displayName": "Pacira BioSciences", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]